PEOPLE - - Xenomics makes appointment:
This article was originally published in Clinica
Executive Summary
Xenomics, an applied genomics firm, has appointed Randy White as CEO. Prior to joining the New York-based developer of noninvasive technology using urine samples rather than blood samples to evaluate genetic markers of disease, such as renal - Dr White served as CEO of Nanogen, and also served at American Medical Diagnostics, which was sold to Quest Diagnostics in 2002.